-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharm.
com.
cn, March 11, the world's most innovative 10 biotech companies: Pfizer, AZ, GSK.
.
.
com.
cn, March 11, the world's most innovative 10 biotech companies: Pfizer, AZ, GSK.
.
.
The daily operation of global business is over.
In every industry, companies around the world have faced practical and survival challenges in the past 12 months.
Some failed, many companies just survived, and a few companies thrived, reshaping their businesses and clarifying the way forward for other companies.
In every industry, companies around the world have faced practical and survival challenges in the past 12 months.
Some failed, many companies just survived, and a few companies thrived, reshaping their businesses and clarifying the way forward for other companies.
From the biotech companies behind the first mRNA vaccines (Pfizer BioNTech and Moderna) to real estate developers providing high-quality affordable housing (Stablegold Hospitality), the world’s 50 most innovative companies are committed to solving COVID-19 transformation Society.
In response, the well-known American business media "Quick Company" announced the "list of the world's 50 most innovative companies", which involved 10 selected companies in the field of biotechnology.
1.
Moderna
Moderna
Moderna's mRNA-based COVID-19 vaccine showed an efficiency of 94% after two injections and can be stored in a regular refrigerator or freezer, becoming the second of its kind authorized by the FDA.
Tied 1, Pfizer/BioNTech takes the lead in bringing an effective COVID-19 vaccine to the market
Even without the help of Warp Speed, New York-based pharmaceutical manufacturer Pfizer and German manufacturing partner BioNTech managed to deliver the COVID-19 vaccine in record time, obtained the FDA Emergency Use Authorization (EUA), and managed to deliver the vaccine in less than one time.
Millions of doses were distributed within a year, and the genetic sequence of COVID-19 was obtained first.
Millions of doses were distributed within a year, and the genetic sequence of COVID-19 was obtained first.
3.
Biobot Analytics is used to use sewage to detect the next outbreak of disease
Biobot Analytics is used to use sewage to detect the next outbreak of disease
Wastewater epidemiology startup Biobot Analytics uses genomic and chemical analysis and data analysis to detect viruses, bacteria and chemicals in sewage.
When COVID-19 broke out, it quickly figured out how to detect the virus in sewage.
When COVID-19 broke out, it quickly figured out how to detect the virus in sewage.
"Sewage testing can catch people who are shedding the virus but have no symptoms.
" Ms.
Mariana Matus, the company's co-founder and computational biologist, said: "We can observe the peak a week before the clinic sees the outbreak.
"
" Ms.
Mariana Matus, the company's co-founder and computational biologist, said: "We can observe the peak a week before the clinic sees the outbreak.
"
4.
Oxford University/AstraZeneca Different ways to find a COVID-19 vaccine
Oxford University/AstraZeneca Different ways to find a COVID-19 vaccine
Unlike Moderna and Pfizer vaccines, the latter uses mRNA to induce cells to produce COVID-19 spike protein, while the Oxford-AstraZeneca vaccine uses DNA hidden in a modified chimpanzee cold virus to trick cells into producing coronavirus antigens.
This DNA-based vaccine does not require freezing and can be refrigerated for up to six months.
It was approved in the UK in December and can maintain a six-month service life under standard cold storage conditions.
This DNA-based vaccine does not require freezing and can be refrigerated for up to six months.
It was approved in the UK in December and can maintain a six-month service life under standard cold storage conditions.
5.
ZYMERGEN makes electronics manufacturing more environmentally friendly through biology
ZYMERGEN makes electronics manufacturing more environmentally friendly through biology
ZYMERGEN, a "biomanufacturer" in Emeryville, California, uses engineered microorganisms to produce industrially less toxic pesticides and sustainable bioplastics.
In 2020, Zymergen cooperated with Sumitomo Chemical of Japan to launch its first commercial product in the electronics industry, which is an ultra-thin film for flexible circuits, display touch sensors and printable electronics.
In 2020, Zymergen cooperated with Sumitomo Chemical of Japan to launch its first commercial product in the electronics industry, which is an ultra-thin film for flexible circuits, display touch sensors and printable electronics.
The company has also developed customized microbial strains to optimize the production of animal feed, reducing the manufacturer's carbon dioxide emissions by approximately 80,000 tons per year, and is developing microbes that can decompose plastics.
Zymergen raised $300 million in Series D financing in September.
Zymergen raised $300 million in Series D financing in September.
6.
TWIST BIOSCIENCE-used to print RNA for virus diagnosis
TWIST BIOSCIENCE-used to print RNA for virus diagnosis
As one of the leading manufacturers of synthetic DNA for research and industrial use, San Francisco-based Twist Bioscience played a pivotal role in the COVID-19 hit and adjusted its method of "writing" DNA on silicon chips to produce better Fine RNA.
It quickly developed a synthetic "control" version of the SARS-CoV-2 virus, and many laboratories have used it to develop and validate tests and antibodies for the virus without the risk of exposure to the virus itself.
Twist also launched its respiratory virus panel, which can detect COVID-19, MERS, SARS and other strains of coronavirus, influenza, pneumonia and other viruses.
Twist also launched its respiratory virus panel, which can detect COVID-19, MERS, SARS and other strains of coronavirus, influenza, pneumonia and other viruses.
7.
GlaxoSmithKline-used to build a drug pipeline powered by genetic evidence
GlaxoSmithKline-used to build a drug pipeline powered by genetic evidence
In the past two years, GlaxoSmithKline (GSK) has received more than ten new approvals for drugs and vaccines (nine in 2020 alone).
In order to demonstrate its commitment to the development of genetically validated drugs, GSK collaborated with the pioneers of CRISPR and worked with 23andMe on early plans for nearly 30 projects in cancer, nervous system, cardiovascular and metabolic diseases.
In order to demonstrate its commitment to the development of genetically validated drugs, GSK collaborated with the pioneers of CRISPR and worked with 23andMe on early plans for nearly 30 projects in cancer, nervous system, cardiovascular and metabolic diseases.
8.
Sherlock Biosciences-Speeding up diagnostic testing through synthetic biology
Sherlock Biosciences-Speeding up diagnostic testing through synthetic biology
Sherlock Biosciences, a CRISPR-based diagnostic company, has developed the first CRISPR-based COVID-19 test kit authorized by the FDA, which can return results in about an hour (compared to the four to six hours of processing for traditional tests).
In November last year, the company received a $5 million grant from the Bill and Melinda Gates Foundation to develop a one-time, over-the-counter version of the new crown test.
In November last year, the company received a $5 million grant from the Bill and Melinda Gates Foundation to develop a one-time, over-the-counter version of the new crown test.
9.
Atomwise -used to combine molecular puzzle pieces together
Atomwise -used to combine molecular puzzle pieces together
San Francisco-based Atomwise uses AI for structure-based small molecule drug discovery, aiming to shorten the development cycle of months or years for partners such as Eli Lilly and Bridge Biotherapeutics.
In April 2020, it expanded its strategic partnership with China's leading biopharmaceutical company Hausen Pharmaceuticals to develop new oncology drugs, and advanced a project with Bayer to develop new crop protection products.
10.
10X Genomics- Bringing single-cell genomics into mainstream science
10X Genomics- Bringing single-cell genomics into mainstream science
10x Genomics provides hardware and software for single cell analysis, which can help researchers pinpoint cell changes in specific tissue types or tumor slices.
By 2020, it has obtained about 250 patents, and there are about 500 pending applications.
A new spatial molecular profiling tool enables researchers to understand the relationship between cells, thereby creating a " map " of gene expression in the entire tumor or tissue sample , and developing highly targeted new therapies.
By 2020, it has obtained about 250 patents, and there are about 500 pending applications.
A new spatial molecular profiling tool enables researchers to understand the relationship between cells, thereby creating a " map " of gene expression in the entire tumor or tissue sample , and developing highly targeted new therapies.
To some extent, the new crown epidemic, as an important social variable, has reshaped the social form, and as a biotechnology company closely related to the epidemic, it has also made important contributions to it.
It is worth noting that these forces complement each other, and the epidemic will also promote the rise and development of a group of biotech companies.
It is worth noting that these forces complement each other, and the epidemic will also promote the rise and development of a group of biotech companies.
Pharm.
com.
cn, March 11, the world's most innovative 10 biotech companies: Pfizer, AZ, GSK.
.
.
com.
cn, March 11, the world's most innovative 10 biotech companies: Pfizer, AZ, GSK.
.
.
The daily operation of global business is over.
In every industry, companies around the world have faced practical and survival challenges in the past 12 months.
Some failed, many companies just survived, and a few companies thrived, reshaping their businesses and clarifying the way forward for other companies.
In every industry, companies around the world have faced practical and survival challenges in the past 12 months.
Some failed, many companies just survived, and a few companies thrived, reshaping their businesses and clarifying the way forward for other companies.
From the biotech companies behind the first mRNA vaccines (Pfizer BioNTech and Moderna) to real estate developers providing high-quality affordable housing (Stablegold Hospitality), the world’s 50 most innovative companies are committed to solving COVID-19 transformation Society.
In response, the well-known American business media "Quick Company" announced the "list of the world's 50 most innovative companies", which involved 10 selected companies in the field of biotechnology.
1.
Moderna
Moderna
Moderna's mRNA-based COVID-19 vaccine showed an efficiency of 94% after two injections and can be stored in a regular refrigerator or freezer, becoming the second of its kind authorized by the FDA.
Tied 1, Pfizer/BioNTech takes the lead in bringing an effective COVID-19 vaccine to the market
Even without the help of Warp Speed, New York-based pharmaceutical manufacturer Pfizer and German manufacturing partner BioNTech managed to deliver the COVID-19 vaccine in record time, obtained the FDA Emergency Use Authorization (EUA), and managed to deliver the vaccine in less than one time.
Millions of doses were distributed within a year, and the genetic sequence of COVID-19 was obtained first.
Millions of doses were distributed within a year, and the genetic sequence of COVID-19 was obtained first.
3.
Biobot Analytics is used to use sewage to detect the next outbreak of disease
Biobot Analytics is used to use sewage to detect the next outbreak of disease
Wastewater epidemiology startup Biobot Analytics uses genomic and chemical analysis and data analysis to detect viruses, bacteria and chemicals in sewage.
When COVID-19 broke out, it quickly figured out how to detect the virus in sewage.
When COVID-19 broke out, it quickly figured out how to detect the virus in sewage.
"Sewage testing can catch people who are shedding the virus but have no symptoms.
" Ms.
Mariana Matus, the company's co-founder and computational biologist, said: "We can observe the peak a week before the clinic sees the outbreak.
"
" Ms.
Mariana Matus, the company's co-founder and computational biologist, said: "We can observe the peak a week before the clinic sees the outbreak.
"
4.
Oxford University/AstraZeneca Different ways to find a COVID-19 vaccine
Oxford University/AstraZeneca Different ways to find a COVID-19 vaccine
Unlike Moderna and Pfizer vaccines, the latter uses mRNA to induce cells to produce COVID-19 spike protein, while the Oxford-AstraZeneca vaccine uses DNA hidden in a modified chimpanzee cold virus to trick cells into producing coronavirus antigens.
This DNA-based vaccine does not require freezing and can be refrigerated for up to six months.
It was approved in the UK in December and can maintain a six-month service life under standard cold storage conditions.
This DNA-based vaccine does not require freezing and can be refrigerated for up to six months.
It was approved in the UK in December and can maintain a six-month service life under standard cold storage conditions.
5.
ZYMERGEN makes electronics manufacturing more environmentally friendly through biology
ZYMERGEN makes electronics manufacturing more environmentally friendly through biology
ZYMERGEN, a "biomanufacturer" in Emeryville, California, uses engineered microorganisms to produce industrially less toxic pesticides and sustainable bioplastics.
In 2020, Zymergen cooperated with Sumitomo Chemical of Japan to launch its first commercial product in the electronics industry, which is an ultra-thin film for flexible circuits, display touch sensors and printable electronics.
In 2020, Zymergen cooperated with Sumitomo Chemical of Japan to launch its first commercial product in the electronics industry, which is an ultra-thin film for flexible circuits, display touch sensors and printable electronics.
The company has also developed customized microbial strains to optimize the production of animal feed, reducing the manufacturer's carbon dioxide emissions by approximately 80,000 tons per year, and is developing microbes that can decompose plastics.
Zymergen raised $300 million in Series D financing in September.
Zymergen raised $300 million in Series D financing in September.
6.
TWIST BIOSCIENCE-used to print RNA for virus diagnosis
TWIST BIOSCIENCE-used to print RNA for virus diagnosis
As one of the leading manufacturers of synthetic DNA for research and industrial use, San Francisco-based Twist Bioscience played a pivotal role in the COVID-19 hit and adjusted its method of "writing" DNA on silicon chips to produce better Fine RNA.
It quickly developed a synthetic "control" version of the SARS-CoV-2 virus, and many laboratories have used it to develop and validate tests and antibodies for the virus without the risk of exposure to the virus itself.
Twist also launched its respiratory virus panel, which can detect COVID-19, MERS, SARS and other strains of coronavirus, influenza, pneumonia and other viruses.
Twist also launched its respiratory virus panel, which can detect COVID-19, MERS, SARS and other strains of coronavirus, influenza, pneumonia and other viruses.
7.
GlaxoSmithKline-used to build a drug pipeline powered by genetic evidence
GlaxoSmithKline-used to build a drug pipeline powered by genetic evidence
In the past two years, GlaxoSmithKline (GSK) has received more than ten new approvals for drugs and vaccines (nine in 2020 alone).
In order to demonstrate its commitment to the development of genetically validated drugs, GSK collaborated with the pioneers of CRISPR and worked with 23andMe on early plans for nearly 30 projects in cancer, nervous system, cardiovascular and metabolic diseases.
In order to demonstrate its commitment to the development of genetically validated drugs, GSK collaborated with the pioneers of CRISPR and worked with 23andMe on early plans for nearly 30 projects in cancer, nervous system, cardiovascular and metabolic diseases.
8.
Sherlock Biosciences-Speeding up diagnostic testing through synthetic biology
Sherlock Biosciences-Speeding up diagnostic testing through synthetic biology
Sherlock Biosciences, a CRISPR-based diagnostic company, has developed the first CRISPR-based COVID-19 test kit authorized by the FDA, which can return results in about an hour (compared to the four to six hours of processing for traditional tests).
In November last year, the company received a $5 million grant from the Bill and Melinda Gates Foundation to develop a one-time, over-the-counter version of the new crown test.
In November last year, the company received a $5 million grant from the Bill and Melinda Gates Foundation to develop a one-time, over-the-counter version of the new crown test.
9.
Atomwise -used to combine molecular puzzle pieces together
Atomwise -used to combine molecular puzzle pieces together
San Francisco-based Atomwise uses AI for structure-based small molecule drug discovery, aiming to shorten the development cycle of months or years for partners such as Eli Lilly and Bridge Biotherapeutics.
In April 2020, it expanded its strategic partnership with China's leading biopharmaceutical company Hausen Pharmaceuticals to develop new oncology drugs, and advanced a project with Bayer to develop new crop protection products.
10.
10X Genomics- Bringing single-cell genomics into mainstream science
10X Genomics- Bringing single-cell genomics into mainstream science
10x Genomics provides hardware and software for single cell analysis, which can help researchers pinpoint cell changes in specific tissue types or tumor slices.
By 2020, it has obtained about 250 patents, and there are about 500 pending applications.
A new spatial molecular profiling tool enables researchers to understand the relationship between cells, thereby creating a " map " of gene expression in the entire tumor or tissue sample , and developing highly targeted new therapies.
By 2020, it has obtained about 250 patents, and there are about 500 pending applications.
A new spatial molecular profiling tool enables researchers to understand the relationship between cells, thereby creating a " map " of gene expression in the entire tumor or tissue sample , and developing highly targeted new therapies.
To some extent, the new crown epidemic, as an important social variable, has reshaped the social form, and as a biotechnology company closely related to the epidemic, it has also made important contributions to it.
It is worth noting that these forces complement each other, and the epidemic will also promote the rise and development of a group of biotech companies.
It is worth noting that these forces complement each other, and the epidemic will also promote the rise and development of a group of biotech companies.
Pharm.
com.
cn, March 11, the world's most innovative 10 biotech companies: Pfizer, AZ, GSK.
.
.
com.
cn, March 11, the world's most innovative 10 biotech companies: Pfizer, AZ, GSK.
.
.
The daily operation of global business is over.
In every industry, companies around the world have faced practical and survival challenges in the past 12 months.
Some failed, many companies just survived, and a few companies thrived, reshaping their businesses and clarifying the way forward for other companies.
Enterprise business enterpriseIn every industry, companies around the world have faced practical and survival challenges in the past 12 months.
Some failed, many companies just survived, and a few companies thrived, reshaping their businesses and clarifying the way forward for other companies.
From the biotech companies behind the first mRNA vaccines (Pfizer BioNTech and Moderna) to real estate developers providing high-quality affordable housing (Stablegold Hospitality), the world’s 50 most innovative companies are committed to solving COVID-19 transformation Society.
In response, the well-known American business media "Quick Company" announced the "list of the world's 50 most innovative companies", which involved 10 selected companies in the field of biotechnology.
1.
Moderna
1. Moderna
Moderna
Moderna's mRNA-based COVID-19 vaccine showed an efficiency of 94% after two injections and can be stored in a regular refrigerator or freezer, becoming the second of its kind authorized by the FDA.
Tied 1, Pfizer/BioNTech takes the lead in bringing an effective COVID-19 vaccine to the market
Even without the help of Warp Speed, New York-based pharmaceutical manufacturer Pfizer and German manufacturing partner BioNTech managed to deliver the COVID-19 vaccine in record time, obtained the FDA Emergency Use Authorization (EUA), and managed to deliver the vaccine in less than one time.
Millions of doses were distributed within a year, and the genetic sequence of COVID-19 was obtained first.
Millions of doses were distributed within a year, and the genetic sequence of COVID-19 was obtained first.
3.
Biobot Analytics is used to use sewage to detect the next outbreak of disease
Disease disease diseaseBiobot Analytics is used to use sewage to detect the next outbreak of disease
Wastewater epidemiology startup Biobot Analytics uses genomic and chemical analysis and data analysis to detect viruses, bacteria and chemicals in sewage.
When COVID-19 broke out, it quickly figured out how to detect the virus in sewage.
When COVID-19 broke out, it quickly figured out how to detect the virus in sewage.
"Sewage testing can catch people who are shedding the virus but have no symptoms.
" Ms.
Mariana Matus, the company's co-founder and computational biologist, said: "We can observe the peak a week before the clinic sees the outbreak.
"
" Ms.
Mariana Matus, the company's co-founder and computational biologist, said: "We can observe the peak a week before the clinic sees the outbreak.
"
4.
Oxford University/AstraZeneca Different ways to find a COVID-19 vaccine
Oxford University/AstraZeneca Different ways to find a COVID-19 vaccine
Unlike Moderna and Pfizer vaccines, the latter uses mRNA to induce cells to produce COVID-19 spike protein, while the Oxford-AstraZeneca vaccine uses DNA hidden in a modified chimpanzee cold virus to trick cells into producing coronavirus antigens.
This DNA-based vaccine does not require freezing and can be refrigerated for up to six months.
It was approved in the UK in December and can maintain a six-month service life under standard cold storage conditions.
Standard Standard StandardThis DNA-based vaccine does not require freezing and can be refrigerated for up to six months.
It was approved in the UK in December and can maintain a six-month service life under standard cold storage conditions.
5.
ZYMERGEN makes electronics manufacturing more environmentally friendly through biology
5. ZYMERGEN makes electronics manufacturing more environmentally friendly through biology
ZYMERGEN makes electronics manufacturing more environmentally friendly through biology
ZYMERGEN, a "biomanufacturer" in Emeryville, California, uses engineered microorganisms to produce industrially less toxic pesticides and sustainable bioplastics.
In 2020, Zymergen cooperated with Sumitomo Chemical of Japan to launch its first commercial product in the electronics industry, which is an ultra-thin film for flexible circuits, display touch sensors and printable electronics.
In 2020, Zymergen cooperated with Sumitomo Chemical of Japan to launch its first commercial product in the electronics industry, which is an ultra-thin film for flexible circuits, display touch sensors and printable electronics.
The company has also developed customized microbial strains to optimize the production of animal feed, reducing the manufacturer's carbon dioxide emissions by approximately 80,000 tons per year, and is developing microbes that can decompose plastics.
Zymergen raised $300 million in Series D financing in September.
Zymergen raised $300 million in Series D financing in September.
6.
TWIST BIOSCIENCE-used to print RNA for virus diagnosis
TWIST BIOSCIENCE-used to print RNA for virus diagnosis
As one of the leading manufacturers of synthetic DNA for research and industrial use, San Francisco-based Twist Bioscience played a pivotal role in the COVID-19 hit and adjusted its method of "writing" DNA on silicon chips to produce better Fine RNA.
It quickly developed a synthetic "control" version of the SARS-CoV-2 virus, and many laboratories have used it to develop and validate tests and antibodies for the virus without the risk of exposure to the virus itself.
Twist also launched its respiratory virus panel, which can detect COVID-19, MERS, SARS and other strains of coronavirus, influenza, pneumonia and other viruses.
Twist also launched its respiratory virus panel, which can detect COVID-19, MERS, SARS and other strains of coronavirus, influenza, pneumonia and other viruses.
7.
GlaxoSmithKline-used to build a drug pipeline powered by genetic evidence
7. GlaxoSmithKline-used to build a drug pipeline powered by genetic evidence
GlaxoSmithKline-used to build a drug pipeline powered by genetic evidence
In the past two years, GlaxoSmithKline (GSK) has received more than ten new approvals for drugs and vaccines (nine in 2020 alone).
In order to demonstrate its commitment to the development of genetically validated drugs, GSK collaborated with the pioneers of CRISPR and worked with 23andMe on early plans for nearly 30 projects in cancer, nervous system, cardiovascular and metabolic diseases.
Medicine, medicine, medicineIn order to demonstrate its commitment to the development of genetically validated drugs, GSK collaborated with the pioneers of CRISPR and worked with 23andMe on early plans for nearly 30 projects in cancer, nervous system, cardiovascular and metabolic diseases.
8.
Sherlock Biosciences-Speeding up diagnostic testing through synthetic biology
Sherlock Biosciences-Speeding up diagnostic testing through synthetic biology
Sherlock Biosciences, a CRISPR-based diagnostic company, has developed the first CRISPR-based COVID-19 test kit authorized by the FDA, which can return results in about an hour (compared to the four to six hours of processing for traditional tests).
In November last year, the company received a $5 million grant from the Bill and Melinda Gates Foundation to develop a one-time, over-the-counter version of the new crown test.
In November last year, the company received a $5 million grant from the Bill and Melinda Gates Foundation to develop a one-time, over-the-counter version of the new crown test.
9.
Atomwise -used to combine molecular puzzle pieces together
9. Atomwise -used to combine molecular puzzle pieces together
Atomwise -used to combine molecular puzzle pieces together
San Francisco-based Atomwise uses AI for structure-based small molecule drug discovery, aiming to shorten the development cycle of months or years for partners such as Eli Lilly and Bridge Biotherapeutics.
In April 2020, it expanded its strategic partnership with China's leading biopharmaceutical company Hausen Pharmaceuticals to develop new oncology drugs, and advanced a project with Bayer to develop new crop protection products.
10.
10X Genomics- Bringing single-cell genomics into mainstream science
10. 10X Genomics- Bringing single-cell genomics into mainstream science
10X Genomics- Bringing single-cell genomics into mainstream science
10x Genomics provides hardware and software for single cell analysis, which can help researchers pinpoint cell changes in specific tissue types or tumor slices.
By 2020, it has obtained about 250 patents, and there are about 500 pending applications.
A new spatial molecular profiling tool enables researchers to understand the relationship between cells, thereby creating a " map " of gene expression in the entire tumor or tissue sample , and developing highly targeted new therapies.
Atlas Atlas AtlasBy 2020, it has obtained about 250 patents, and there are about 500 pending applications.
A new spatial molecular profiling tool enables researchers to understand the relationship between cells, thereby creating a " map " of gene expression in the entire tumor or tissue sample , and developing highly targeted new therapies.
To some extent, the new crown epidemic, as an important social variable, has reshaped the social form, and as a biotechnology company closely related to the epidemic, it has also made important contributions to it.
It is worth noting that these forces complement each other, and the epidemic will also promote the rise and development of a group of biotech companies.
It is worth noting that these forces complement each other, and the epidemic will also promote the rise and development of a group of biotech companies.
